Analysis of Evotec SE (0IRF)
Evotec SE (0IRF) has been showing strong bullish momentum recently, with the RSI indicator reaching high levels above 70 in the last few days. The MACD indicator has also been positive, indicating a bullish trend.
On the price side, the stock has been trading in an uptrend, with the price closing higher than the opening price in the last few days. The moving averages (SMA, EMA, WMA) have been showing an upward trend, supporting the bullish momentum.
Overall, based on the technical indicators and price action, Evotec SE seems to be in a strong bullish phase. Traders and investors may consider this stock for further analysis and potential trading opportunities.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the transfer agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a specific company. Here are the key points:
1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total cash per share is $4.379. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.43. Gross profit TTM is $169,148,000,000. Revenue per share TTM is $24.537. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets (ROA)**: ROA TTM is 22.073999%.
- **Return on Equity (ROE)**: ROE TTM is 147.25%.
2. **Stock Statistics**:
- Short ratio is 1.53.
- Float shares are 15,308,320,742.
- Shares short are 99,287,450.
- Average 10-day volume is 46,860,048.
- Average 90-day volume is 57,498,254.
- Shares outstanding are 15,334,099,968.
- Percent held by insiders is 5.22%.
- Percent held by institutions is 57.589%.
- Short percent of shares outstanding is 0.65%.
3. **Valuations Metrics**:
- PEG ratio is 26.319502.
- Forward PE ratio is 26.319502.
- Trailing PE ratio is 29.59409.
- Enterprise value is $2,950,762,332,160.
- Price to book ratio on a quarterly basis is 39.3405.
- Price to sales TTM is 7.646095.
- Enterprise to EBITDA ratio is 22.763.
- Enterprise to revenue ratio is 7.732.
- Market capitalization is $2,917,925,650,432.
4. **Stock Price Summary**:
- Beta is 1.264.
- 50-day moving average is $176.2646.
- 200-day moving average is $181.0429.
- 52-week low is $164.08.
- 52-week high is $199.62.
- 52-week change is 6.853%.
5. **Dividends and Splits**:
- Payout ratio is 14.93%.
- Dividend date is May 16, 2024.
- Last split date was August 31, 2020 (4-for-1 split).
- Ex-dividend date is May 10, 2024.
- Forward annual dividend rate is $1.
- 5-year average dividend yield is 0.73%.
- Forward annual dividend yield is 0.5255%.
- Trailing annual dividend rate is $0.97.
- Trailing annual dividend yield is 0.5097%.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly high growth rate projected for the next 5 years. This indicates positive expectations and potential for expansion in the company's performance.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general trend of increasing revenue over the years.
- The highest revenue was recorded in FY 2022.
These trends can provide insights into the company's performance and may indicate shifts in market conditions, consumer behavior, or the company's strategic decisions.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated but generally show an increasing trend.
3. Non-current assets have also been increasing steadily.
4. Total liabilities have been increasing, but at a slower pace compared to total assets.
5. Shareholders' equity has been increasing over the years.
6. The company has been investing more in non-current assets like investments and advances, machinery, furniture, and equipment.
7. The company has been relying more on long-term debt to finance its operations.
8. The company has been managing its current liabilities effectively.
9. The company has been retaining earnings and increasing common stock over the years.
10. Overall, the financial health of the company seems to be stable and improving.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
5. Investing activities reflect significant amounts related to the sale and purchase of investments, as well as capital expenditures.
6. The end cash position has also been fluctuating, with the highest value in 2020 and the lowest in 2022.
These conclusions provide insights into the company's financial performance and management of cash flows over the years.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an improvement from the EPS of $6.59 from the prior year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual periods.MACD of 0IRF